NASDAQ : AXNX
Axonex AI Group Limited — Key statistics
Healthcare · Medical Devices · Hong Kong
Last price 1.03 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.42M |
| Enterprise Value | 6.47M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.08M |
| Shares Outstanding | 6.36M |
| Shares Change (YoY) | +15.96% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 30.38% |
| Owned by Institutions (%) | 8.90% |
| Float | 4.43M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.94 |
| Forward PS | n/a |
| PB Ratio | 0.32 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -346.62 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -227.11% |
| Return on Assets (ROA) | -98.33% |
| Return on Invested Capital (ROIC) | -305.48% |
| Return on Capital Employed (ROCE) | -245.93% |
| Weighted Average Cost of Capital (WACC) | 7.88% |
| Revenue Per Employee | $63,628 |
| Profits Per Employee | -$286,519 |
| Employee Count | 36 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 4,926 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -99.12% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 5.77 |
| Relative Strength Index (RSI) | 34.04 |
| Average Volume (20 Days) | 537,007 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 691,308 |
| Short Previous Month | 902,159 |
| Short % of Shares Out | 10.87% |
| Short % of Float | 15.62% |
| Short Ratio (days to cover) | 0.29 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.29M |
| Gross Profit | 249,997 |
| Operating Income | -10.19M |
| Pretax Income | -10.31M |
| Net Income | -10.31M |
| EBITDA | -10.04M |
| EBIT | -10.19M |
| Loss Per Share | -$10.38 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.03M |
| Total Debt | 1.08M |
| Net Cash | -50,624 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 3.28M |
| Book Value Per Share | 3.28 |
| Working Capital | 1.09M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -858,394 |
| Capital Expenditures | -205,054 |
| Depreciation & Amortization | 147,976 |
| Net Borrowing | -103,786 |
| Free Cash Flow | -1.06M |
| FCF Per Share | -$0.17 |
Margins
| Measure | Value |
|---|
| Gross Margin | 10.91% |
| Operating Margin | -444.75% |
| Pretax Margin | -450.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.96% |
| Shareholder Yield | -15.96% |
| Earnings Yield | -1,027.71% |
| FCF Yield | -15.78% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:2.5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 20.21 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |